Showing 2,741 - 2,760 results of 24,535 for search 'LiveAD~', query time: 4.61s Refine Results
  1. 2741
  2. 2742

    Human Liver Cells Expressing Albumin and Mesenchymal Characteristics Give Rise to Insulin-Producing Cells by Irit Meivar-Levy, Tamar Sapir, Dana Berneman, Tal Weissbach, Sylvie Polak-Charcon, Philippe Ravassard, Andreas G. Tzakis, Eytan Mor, Camillo Ricordi, Sarah Ferber

    Published 2011-01-01
    “…Activation of the pancreatic lineage in the liver has been suggested as a potential autologous cell replacement therapy for diabetic patients. …”
    Get full text
    Article
  3. 2743
  4. 2744

    Behavior of liver cirrhosis at the "Arnaldo Milian Castro" Hospital from July 2007 to March 2009 by María Herminia Fajardo González, Merlyn Arce Nuñez, Yosvany Medina Garrido, Lisset Esteva Carral, Marcos Félix Osorio Pagola

    Published 2010-08-01
    “…<strong>Background</strong>: Liver cirrhosis is among the top ten death causes in the developed world and also in Cuba, so it is important to know its clinical and epidemiological characteristics in order to propose appropriate preventive measures. …”
    Get full text
    Article
  5. 2745
  6. 2746
  7. 2747

    Marijuana Use in Hepatitis C Infection does not Affect Liver Biopsy Histology or Treatment Outcomes by Theresa Liu, Glen T Howell, Lucy Turner, Kimberley Corace, Gary Garber, Curtis Cooper

    Published 2014-01-01
    “…The literature assessing the influence of marijuana on liver disease progression and hepatitis C virus antiviral treatment outcomes is conflicting.…”
    Get full text
    Article
  8. 2748
  9. 2749

    Concurrent Hepatic Artery and Portal Vein Thrombosis after Orthotopic Liver Transplantation with Preserved Allografts by Arshad Khan, P. Park, Jose Oberholzer, Ivo Tzvetanov, Raquel Garcia Roca, Ron C. Gaba, Enrico Benedetti, Hoonbae Jeon

    Published 2014-01-01
    “…Patent portal flow makes an important contribution to the viability of liver in case of late HAT while the allograft reconstitutes intrahepatic arterial flow through neovascularization. …”
    Get full text
    Article
  10. 2750
  11. 2751

    Rescue ALPPS: Intraoperative Conversion to ALPPS during Synchronous Resection of Rectal Cancer and Liver Metastasis by Terence Jackson, Kelly A. Siegel, Christopher T. Siegel

    Published 2014-01-01
    “…With portal vein ligation alone or when combined with sequential hepatectomy, there is also a risk for inadequate liver hypertrophy because of intrahepatic portal collaterals leading to a high (19–30%) dropout rate. …”
    Get full text
    Article
  12. 2752
  13. 2753

    Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study by Steven Dooley, Juan Du, Xiaoping Tang, Lan Chen, Jinzhu Jia, Fujun Li, Yanyan Shi, Christoph Meyer, Zhongwei Zhu, Yanming Zhang, Roman Liebe, Keming Hu, Tingting Zhou, Huier Zhang, Hong-Lei Weng, Tong Huang

    Published 2022-06-01
    “…Eleven years of NAFLD are not sufficient to cause severe liver disease. Age and obesity are direct risk factors for NAFLD. …”
    Get full text
    Article
  14. 2754

    Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus by Lung-Wen Tsai, Yi-Hsiang Lu, Rajni Dubey, Jeng-Fong Chiou

    Published 2021-01-01
    “…Reports indicate the increasing prevalence of liver disorders in diabetes mellitus (DM) patients. …”
    Get full text
    Article
  15. 2755

    Protocol for isolating and purifying murine liver sinusoidal endothelial cells for in vitro culture and functional assays by Sophia Papaioannou, Jia-Xiang See, Tinja Baljkas, Philipp Reiners-Koch, Manuel Winkler, Adelheid Cerwenka, Ana Stojanovic

    Published 2025-03-01
    “…Summary: Liver sinusoidal endothelial cells (LSECs) line the liver sinusoids and play a crucial role in liver function. …”
    Get full text
    Article
  16. 2756
  17. 2757

    Insulin Resistance Markers to Detect Nonalcoholic Fatty Liver Disease in a Male Hispanic Population by Maritza Pérez-Mayorga, Jose P. Lopez-Lopez, Maria A. Chacon-Manosalva, Maria G Castillo, Johanna Otero, Daniel Martinez-Bello, Diego Gomez-Arbelaez, Daniel D. Cohen, Patricio Lopez-Jaramillo

    Published 2022-01-01
    “…Background. Nonalcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver disease and is closely associated with cardiometabolic disorders, being insulin resistance (IR) the common pathogenic mechanism. …”
    Get full text
    Article
  18. 2758

    Urgent Splenectomy after Partial Splenic Embolization in Liver-Transplanted Patient: A Case Report by Jorge Herrador Benito, M. G. Zunzarren, T. Pozancos de Simón, L. Tortolero, R. Latorre Fragua, J. Nuño, E. Lobo

    Published 2012-01-01
    “…We describe a 51-year-old-male. Three months after liver transplantation due to hepatitis C virus (HCV) hepatopathy, an HCV relapse was detected, and partial splenic embolization (PSE) was performed prior to antiviral treatment. …”
    Get full text
    Article
  19. 2759

    Dietary caloric input and tumor growth accelerate senescence and modulate liver and adipose tissue crosstalk by José Xavier do Nascimento Júnior, Júlia da Conceição Gomes, Ricardo Imbroisi Filho, Helber de Maia Valença, Jéssica Ristow Branco, Amanda Bandeira Araújo, Amanda de Oliveira Esteves Moreira, Letícia Diniz Crepaldi, Larissa Pereira Paixão, Alan C. Ochioni, Thainá M. Demaria, João Gabriel Bernardo Leandro, Livia Marques Casanova, Mauro Sola-Penna, Patricia Zancan

    Published 2025-01-01
    “…Consequently, through an increased expression of lactate, IGFBP3, and PTHLH, tumors modulate liver and white adipose tissue metabolism. In the liver, the induced tumor increases fibrosis and accelerates the senescence process, despite the lower systemic pro-inflammatory state. …”
    Get full text
    Article
  20. 2760

    The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background by Jinsheng Yu, Sharon Marsh, Junbo Hu, Wenke Feng, Chaodong Wu

    Published 2016-01-01
    “…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and it comprises a spectrum of hepatic abnormalities from simple hepatic steatosis to steatohepatitis, fibrosis, cirrhosis, and liver cancer. …”
    Get full text
    Article